Can low or low-normal vitamin B12 cause fatigue and cognitive symptoms before macrocytic anemia appears?

Vitamin B12 is essential for maintaining both the structural integrity and the metabolic efficiency of the central nervous system. In older adults, such as those in their late 60s, ensuring adequate status is critical, as deficiency often manifests with neurological or cognitive symptoms long before traditional blood markers, like macrocytic anemia, become apparent.

Mechanistic basis for neurologic function

Vitamin B12 operates through two distinct biochemical pathways that directly support brain health:

• Energy Metabolism: As deoxyadenosylcobalamin, B12 is a mandatory cofactor for the mitochondrial enzyme methylmalonyl-CoA mutase. This enzyme converts methylmalonyl-CoA into succinyl-CoA, a vital intermediate in the citric acid (TCA) cycle. Because neurons are highly energy-dependent, this pathway is essential for ATP production.
• Myelin Integrity: As methylcobalamin, B12 facilitates the conversion of homocysteine to methionine, a precursor to S-adenosylmethionine (SAM). SAM is the primary methyl donor required for the methylation of myelin basic protein (MBP) by oligodendrocytes. Without this process, the structural maintenance of the myelin sheath—the insulation for nerve fibers—is compromised.

Clinical evidence for cognitive and fatigue symptoms

Low B12 status is strongly linked to cognitive decline and fatigue, particularly in populations where malabsorption is more common.

• Overt Deficiency: Levels below 200 pg/mL are definitively associated with significant cognitive impairment and fatigue, which are often reversible with appropriate supplementation.
• Low-Normal Status: Evidence suggests that "low-normal" levels (200–400 pg/mL) can also be problematic. Some cohort studies show that individuals with levels below 350 pg/mL perform significantly worse on cognitive assessments, such as the MMSE and Trail Making Tests, compared to those with higher levels.
• Functional Deficiency: Serum B12 is considered a late-stage marker. Functional deficiency—where tissue-level deficits occur despite "normal" blood levels—can be identified by elevated methylmalonic acid (MMA) or homocysteine, markers that reflect impaired cellular metabolism.

Neurological symptoms without anemia

A critical clinical finding is the "neurological-hematological dissociation," where cognitive and neurological symptoms precede changes in red blood cells.

• Distinct Pathways: Hematological changes like macrocytic anemia (enlarged red blood cells) result from impaired DNA synthesis. In contrast, neurological damage is primarily driven by the accumulation of MMA, which is toxic to myelin-producing cells and neurons.
• Symptom Presentation: MMA toxicity often causes cognitive decline, depression, or neuropathy months before erythropoiesis (red blood cell production) is significantly affected. Therefore, a normal mean corpuscular volume (MCV) on a routine blood count does not rule out B12-related neurologic issues.

Bottom line

Vitamin B12 is fundamentally required for neuronal ATP production and myelin maintenance. Cognitive symptoms and fatigue can emerge at "low-normal" B12 levels and frequently occur in the absence of macrocytic anemia, making early screening with sensitive markers like MMA highly relevant for aging populations.